These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 20724485

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse.
    Gyertyán I, Kiss B, Gál K, Laszlovszky I, Horváth A, Gémesi LI, Sághy K, Pásztor G, Zájer M, Kapás M, Csongor EA, Domány G, Tihanyi K, Szombathelyi Z.
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1268-78. PubMed ID: 17170312
    [Abstract] [Full Text] [Related]

  • 3. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
    Dias FR, Carey RJ, Carrera MP.
    Brain Res; 2006 Apr 14; 1083(1):85-95. PubMed ID: 16530737
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
    Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A.
    J Pharmacol Exp Ther; 1995 Dec 14; 275(3):1239-46. PubMed ID: 8531087
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P, Carlson EE, Cao J, Bennett CJ, McElveen E, Taylor M, Luedtke RR, Newman AH.
    J Med Chem; 2005 Feb 10; 48(3):839-48. PubMed ID: 15689168
    [Abstract] [Full Text] [Related]

  • 11. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ, Marshall JF.
    Synapse; 1992 Sep 10; 12(1):14-26. PubMed ID: 1357762
    [Abstract] [Full Text] [Related]

  • 12. Role of dopamine D3 receptors in controlling the expression of cocaine sensitization in rats.
    Filip M, Papla I, Czepiel K.
    Pol J Pharmacol; 2002 Sep 10; 54(6):687-91. PubMed ID: 12866725
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.
    Martelle JL, Claytor R, Ross JT, Reboussin BA, Newman AH, Nader MA.
    J Pharmacol Exp Ther; 2007 May 10; 321(2):573-82. PubMed ID: 17272677
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D, Priebe K, Johnstone-Miller E, Morgan CJ.
    Psychopharmacology (Berl); 2002 Jul 10; 162(2):138-46. PubMed ID: 12110991
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct 10; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 19. [Effects of hemantane on the main subtypes of dopamine receptors in the rat striatum ex vivo].
    Abaimov DA, Zimin IA, Kovalev GI.
    Eksp Klin Farmakol; 2008 Oct 10; 71(1):18-21. PubMed ID: 18365481
    [Abstract] [Full Text] [Related]

  • 20. Behavioral interactions produced by co-administration of 7-OH-DPAT with cocaine or apomorphine in the rat.
    Khroyan TV, Fuchs RA, Beck AM, Groff RS, Neisewander JL.
    Psychopharmacology (Berl); 1999 Mar 10; 142(4):383-92. PubMed ID: 10229063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.